ChemComm
Communication
Table 3 Phosphine-catalyzed [4+1] annulation of 1,3-azadienes 4 and
maleimides 2a
Entry R1 in 4
R2 in 2
Time (h) 5, Yieldb (%)
1
2
3
4
5
6
7
8
Ph (4a)
Ph
Ph
Ph
Ph
Ph (2a)
4-MeC6H4 (2b)
4-NO2C6H4 (2c) 48
Bn (2d)
n-Bu (2e)
Boc (2f)
48
72
5a, 82
5b, 69
5c, 87
5d, 49
Trace
5e, 32
5f, 76
5g, 45
Scheme 3 A proposed mechanism for formation of 3 and 5.
96
96
48
48
48
Ph
spirocyclic product 3u in 88% yield (Scheme 2, a). However, a
methylated analogous ylide 2ab failed to bring about a similar
product (Scheme 2, b).
Based on the above experimental results and closely related
reports,3,8c a plausible mechanism is depicted in Scheme 3 to
account for the formation of 3 or 5. A phosphorus ylide B is
in situ generated via the nucleophilic attack of phosphine at
4-MeOC6H4 (4b) Ph
4-ClC6H4 (4c) Ph
a
Typical conditions: under a N2 atmosphere, a mixture of azadiene 4
(0.2 mmol), maleimide 2 (0.24 mmol), benzoic acid (0.04 mmol) and
Ph3P (0.04 mmol) in CH2Cl2 (2.0 mL) was stirred at rt for a specified time.
b
Isolated yield.
Structurally similar a,b-unsaturated imines 4 as electron- maleimide 2 followed by benzoic acid-aided proton transfer.8c
deficient 1,3-azadienes were also explored under the standard The ylide B then undergoes a Michael addition to electron-
conditions (Table 3). With phenyl-substituted azadiene 4a used deficient diene 1 or azadiene 4 to generate intermediate C,
as a reactant, a series of N-substituted maleimides 2 were which subsequently cyclizes by an intramolecular SN2 mode to
examined (entries 1–6). Except N-butyl maleimide 2e, N-aryl, furnish spirocyclic product 3 or 5 and regenerate the phosphine
N-benzyl, and N-(tert-butoxycarbonyl) maleimides 2 were good catalyst.
substrates in the [4+1] annulations with 4a, readily affording the
In conclusion, we have successfully developed a novel
corresponding products 5 in modest to good yields. Representa- phosphine-catalyzed [4+1] annulation reaction of electron-deficient
tive aryl-substituted 1,3-azadienes 4b and 4c were also examined 1,3-dienes or 1,3-azadienes with maleimides, which provides a
in the reactions with maleimide 2a, smoothly giving the expected convenient and highly efficient method to construct important
azaspirocyclic products 5 in moderate yields (entries 7 and 8). azaspiro[4.4]nonane skeletons. This reaction also represents the
Therefore, 1,3-azadienes 4 were proven to be effective candidates first example of the [4+1] annulation between electron-deficient
in the phosphine-catalyzed [4+1] annulation reaction with 4p-conjugated systems and non-allylic phosphorus ylides by the
maleimides 2, which provided efficient access to highly functiona- Michael addition-intramolecular substitution mode. Further
lized 1,7-diazaspiro[4.4]nonane skeletons.
expanding its scope and developing its asymmetric version are
The structures of products 3 and 5 were well identified by NMR currently under investigation in our laboratory.
(1H, 13C) and HRMS. Representative compounds 3a (CCDC
Financial support from National Natural Science Foundation of
1013074) and 5a (CCDC 1012903) were further confirmed by X-ray China (Grant no. 21121002; 21272119) is gratefully acknowledged.
crystallographic analyses. For detailed spectroscopic data, see ESI.†
To glean some mechanistic insights into the annulation
reaction, the following experiments were deliberately conducted
Notes and references
1 (a) H. Hayashi, Y. Nishimoto and H. Nozaki, Tetrahedron Lett., 1997,
(Scheme 2). In the absence of benzoic acid, a phosphorus ylide
2aa, prepared by a known procedure,10 was treated with equi-
molar diene 1p in CH2Cl2 at rt for 24 h to smoothly give the
38, 5655; (b) J. Obniska, K. Kaminski, A. Zagorska, A. Dzierzawska-
Majewska and J. Karolak-Wojciechowska, J. Fluorine Chem., 2006,
127, 417; (c) J. Obniska, M. Kolaczkowski, A. J. Bojarski and
B. Duszynska, Eur. J. Med. Chem., 2006, 41, 874; (d) K. Kaminski,
J. Obniska and M. Dybala, Eur. J. Med. Chem., 2008, 43, 53; (e) Z. Ma,
D. T. W. Chu, C. S. Cooper, Q. Li, A. K. L. Fung, S. Wang, L. L. Shen,
R. K. Flamm, J. D. Alder, J. A. Meulbrock and O. Y. Sun, J. Med.
Chem., 1999, 42, 4202; ( f ) B. D. Morris and M. R. Prinsep, J. Nat.
Prod., 1999, 62, 688; (g) M. G. Hinds, N. G. J. Richards and
J. A. Robinson, J. Chem. Soc., Chem. Commun., 1988, 1447;
(h) G. Muller, G. Hessler and H. Y. Decornez, Angew. Chem., Int.
Ed., 2000, 39, 894; (i) M. F. Brana, M. Garranzo, B. de Pascual-Teresa,
J. Perez-Castells and M. R. Torres, Tetrahedron, 2002, 58, 4825.
2 (a) S. Tanimori, K. Fukubayashi and M. Kirihata, Biosci., Biotechnol.,
Biochem., 2000, 64, 1758; (b) M. Gutierrez-Rodriguez, M. T. Garcia-Lopez
and R. Herranz, Tetrahedron, 2004, 60, 5177; (c) C. C. Hughes and
D. Trauner, Angew. Chem., Int. Ed., 2002, 41, 4556; (d) K. Sakaguchi,
M. Ayabe, Y. Watanabe, T. Okada, K. Kawamura, T. Shiada and
Y. Ohfune, Org. Lett., 2008, 10, 5449; (e) K. Chiyoda, J. Shimokawa and
T. Fukuyawa, Angew. Chem., Int. Ed., 2012, 51, 2505; ( f ) J. Cossy,
A. Bouzide and C. Leblanc, J. Org. Chem., 2000, 65, 7257; (g) T. Liu,
Scheme 2 Mechanistic investigation.
13508 | Chem. Commun., 2014, 50, 13506--13509
This journal is ©The Royal Society of Chemistry 2014